Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term open-label brexpiprazole maintenance in adolescents with schizophrenia
2017-001459-30Phase 3Completed
- Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Start
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of brexpiprazole in schizophrenia, sponsored by Otsuka Pharmaceutical Co., Ltd. Started Jan 2019; status: completed.
02
Drugs
brexpiprazole
03
Conditions
schizophrenia
Beyond the preview
Go deeper on 2017-001459-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-001459-30.